Alexandra Sokolova, MD

Sokolova is an assistant professor of medicine in the division of hematology/medical oncology at Oregon Health & Science University in Portland.

Articles by Alexandra Sokolova, MD

Alexandra Sokolova, MD, outlines TRIPLE-SWITCH trial in mCSPC

ByAlexandra Sokolova, MD

December 8th 2025

The primary end point is overall survival, with secondary end points including PSA response metrics, progression measures, PSA kinetics, and several ctDNA assessments to help identify which patients benefit most.

Alexandra Sokolova, MD

Articles by Alexandra Sokolova, MD

Alexandra Sokolova, MD, outlines TRIPLE-SWITCH trial in mCSPC

Latest Updated Articles

Trending on Urology Times

Mark Tyson, MD shares promising BOND-003 results in papillary NMIBC

Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC

CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC

Modern frameworks for treating high-risk non–muscle invasive bladder cancer

Choosing salvage therapy after prostate cancer focal ablation